Task: Answer the multiple-choice question.
Query: Which compound exhibits a 16.363% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a: CCN(CC)c1ccc(C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OC)cc1
b: C/C(=N\NC(=O)COc1ccc([N+](=O)[O-])cc1)c1ccco1
c: N#Cc1cnc(SCC(=O)N2CCCCC2)nc1N
d: CCOC(=O)c1c[nH]n2c(=O)cc(C)nc12
Answer: c. N#Cc1cnc(SCC(=O)N2CCCCC2)nc1N
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#Cc1cnc(SCC(=O)N2CCCCC2)nc1N
N#Cc1cnc(SCC(=O)N2CCCCC2)nc1N
4-amino-2-(2-oxo-2-piperidin-1-ylethyl)sulfanylpyrimidine-5-carbonitrile